MOTS-c in adolescent PCOS: a study without a clear group difference
Investigators compared serum measurements and one mitochondrial variant in adolescents with polycystic ovary syndrome and controls.
Human physiology studyPaper year: 2026MOTS-c
01 / DESIGN
What was studied?
Investigators compared serum measurements and one mitochondrial variant in adolescents with polycystic ovary syndrome and controls.
02 / FINDINGS
What did the researchers report?
The serum difference did not meet the study's statistical threshold. All participants carried the same genotype at the investigated position.
03 / INTERPRETATION
What are the limits?
A uniform genotype cannot test the consequences of alternative variants. This observational study provides no evidence that administering MOTS-c changes PCOS outcomes.
Original editorial summary by Sulan Peptide. Based on the source abstract; consult the full paper for methods, analyses, funding and disclosures.
RESEARCH CONTEXT
These are original reading notes on published studies, not product testimonials. Clinical studies used their own pharmaceutical formulations and protocols; their findings do not establish the safety, efficacy or equivalence of materials in our catalog. No personal-use or treatment guidance is provided.
Related catalog navigation only. The supplied material is not established as equivalent to the study product, and the paper does not certify a supply batch.
